Evidence map›Paper›PMID 37506337›Full record

ArticleBlood2023

Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association.

Dominic W Chung, Kimsey Platten, Koya Ozawa, Reheman Adili, Nathalie Pamir, Forrest Nussdorfer, Alexander St John, Minhua Ling, Jennie Le, Jeff Harris and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Dominic W ChungBloodworks Research Institute, Seattle, WA.ORCID 0000-0002-2645-5703
Kimsey PlattenMolecular Cell Biology Program, Washington University in St. Louis, St. Louis, MO.ORCID 0000-0001-9077-7099
Koya OzawaDepartment of Medicine and Health, University of Sydney, Sydney, Australia.ORCID 0000-0002-8401-3727
Reheman AdiliBloodworks Research Institute, Seattle, WA.ORCID 0000-0002-1973-9695
Nathalie PamirCardiovascular Division, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR.ORCID 0000-0002-2074-888X
Forrest NussdorferBloodworks Research Institute, Seattle, WA.
Alexander St JohnDepartment of Emergency Medicine, University of Washington, Seattle, WA.ORCID 0000-0001-6418-8629
Minhua LingBloodworks Research Institute, Seattle, WA.
Jennie LeBloodworks Research Institute, Seattle, WA.
Jeff HarrisBloodworks Research Institute, Seattle, WA.
Nicole RhoadsBloodworks Research Institute, Seattle, WA.ORCID 0000-0001-8331-5136
Yi WangBloodworks Research Institute, Seattle, WA.
Xiaoyun FuBloodworks Research Institute, Seattle, WA.
Junmei ChenBloodworks Research Institute, Seattle, WA.
Sergio FazioCardiovascular Division, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR.
Jonathan R LindnerDepartment of Medicine, University of Virginia, Charlottesville, VA.
José A LópezBloodworks Research Institute, Seattle, WA.
Bloodworks Northwest · USUniversity of Washington · USOregon Health & Science University · USMichigan United · USThe University of Sydney · AUUniversity of Virginia · USWashington University in St. Louis · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Targeted CEU Imaging of Atherosclerosis and AngiogenesisR01HL078610 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 2004 to 2022
$6.8M
Molecular and Translational Studies in Hematologic DisordersR35HL145262 · NHLBI · BLOODWORKS · PI LOPEZ, JOSE ARON · 2019 to 2024
$6.5M
Augmentation of Tissue Perfusion with Ultrasound-mediated CavitationR01HL130046 · NHLBI · UNIVERSITY OF VIRGINIA · PI LINDNER, JONATHAN R · 2016 to 2023
$5.5M
Functional and structural correlates of PCSK9 association with lipoproteinsR01HL132985 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI PAMIR, NATHALIE · 2016 to 2024
$4.2M
Biosynthetic and Functional Consequences of von Willebrand Disease MutationsR01HL117639 · NHLBI · BLOODWORKS · PI LOPEZ, JOSE ARON · 2013 to 2017
$2.9M
Identification of the role of HDL function in human cardiovascular disease through proteomics and geneticsR01HL136373 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI PAMIR, NATHALIE · 2018 to 2022
$2.4M
The Biology of VWF Self-AssociationR01HL137991 · NHLBI · BLOODWORKS · PI CHUNG, DOMINIC W. · 2017 to 2019
$2.0M
The Biology of VWF Self-AssociationR56HL131946 · NHLBI · BLOODWORKS · PI CHUNG, DOMINIC W. · 2016 to 2016
$567k
NHLBI NIH HHS R01 HL078610NHLBI NIH HHS R01 HL117639NHLBI NIH HHS R01 HL130046NHLBI NIH HHS R01 HL132985NHLBI NIH HHS R01 HL136373NHLBI NIH HHS R01 HL137991NHLBI NIH HHS R35 HL145262NHLBI NIH HHS R56 HL131946NIH HHS P51 OD011092
6 · The paper itself

Abstract

von Willebrand factor (VWF) mediates primary hemostasis and thrombosis in response to hydrodynamic forces. We previously showed that high shear promoted self-association of VWF into hyperadhesive strands, which can be attenuated by high-density lipoprotein (HDL) and apolipoprotein A-I. In this study, we show that low-density lipoprotein (LDL) binds VWF under shear and enhances self-association. Vortexing VWF in tubes resulted in its loss from the solution and deposition onto tube surfaces, which was prevented by HDL. At a stabilizing HDL concentration of 1.2 mg/mL, increasing concentrations of LDL progressively increased VWF loss, the effect correlating with the LDL-to-HDL ratio and not the absolute concentration of the lipoproteins. Similarly, HDL diminished deposition of VWF in a post-in-channel microfluidic device, whereas LDL increased both the rate and extent of strand deposition, with both purified VWF and plasma. Hypercholesterolemic human plasma also displayed accelerated VWF accumulation in the microfluidic device. The initial rate of accumulation correlated linearly with the LDL-to-HDL ratio. In Adamts13-/- and Adamts13-/-LDLR-/- mice, high LDL levels enhanced VWF and platelet adhesion to the myocardial microvasculature, reducing cardiac perfusion, impairing systolic function, and producing early signs of cardiomyopathy. In wild-type mice, high plasma LDL concentrations also increased the size and persistence of VWF-platelet thrombi in ionophore-treated mesenteric microvessels, exceeding the accumulation seen in similarly treated ADAMTS13-deficient mice that did not receive LDL infusion. We propose that targeting the interaction of VWF with itself and with LDL may improve the course of thrombotic microangiopathies, atherosclerosis, and other disorders with defective microvascular circulation.

Indexed as

Thrombosisvon Willebrand FactorADAMTS13 ProteinAnimalsHemostasisHumansLipoproteins, LDLMicePlatelet AdhesivenessADAMTS13 ProteinLipoproteins, LDLvon Willebrand Factor

Identifiers

PMID37506337
PMCPMC10541996
OpenAlexW4385334152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.